InterSystems Launches IntelliCare: AI-Powered Next-Gen EHR

InterSystems Launches IntelliCare: AI-Powered Next-Gen EHR InterSystems, a leading provider of innovative data technology managing over a billion health records globally, today unveiled InterSystems IntelliCare, a next-generation, AI-powered electronic health record (EHR) and healthcare information system. IntelliCare is designed to…

Read MoreInterSystems Launches IntelliCare: AI-Powered Next-Gen EHR

Philips Chooses AWS as Preferred Cloud Provider to Drive Innovation and Enhance Patient Outcomes

Philips Chooses AWS as Preferred Cloud Provider to Drive Innovation and Enhance Patient Outcomes Amazon Web Services, Inc. (AWS), part of Amazon.com, Inc. (NASDAQ: AMZN), has announced that Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology,…

Read MorePhilips Chooses AWS as Preferred Cloud Provider to Drive Innovation and Enhance Patient Outcomes

ENCell’s EN001 Gets FDA Orphan Drug Status for Charcot-Marie-Tooth Disease

ENCell’s EN001 Gets FDA Orphan Drug Status for Charcot-Marie-Tooth Disease ENCell, a leading biopharmaceutical company specializing in cell and gene therapy, contract research, and manufacturing, has announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation…

Read MoreENCell’s EN001 Gets FDA Orphan Drug Status for Charcot-Marie-Tooth Disease

MedLumics® Publishes FIM Results for AblaView® Ablation System in AF Patients

MedLumics® Publishes FIM Results for AblaView® Ablation System in AF Patients “We would like to extend our heartfelt thanks to the investigation site team, especially the investigators and proctors, for their invaluable contributions to this groundbreaking first-in-human trial. Their efforts…

Read MoreMedLumics® Publishes FIM Results for AblaView® Ablation System in AF Patients

Elegen Reduces Pricing for ENFINIA™ DNA to Expand Access to Next-Generation Cell-Free DNA Manufacturing

Elegen Reduces Pricing for ENFINIA™ DNA to Expand Access to Next-Generation Cell-Free DNA Manufacturing Elegen, a pioneer in next-generation cell-free DNA manufacturing, has announced a 25% price reduction for its ENFINIA™ DNA products. This move aims to make the industry-leading,…

Read MoreElegen Reduces Pricing for ENFINIA™ DNA to Expand Access to Next-Generation Cell-Free DNA Manufacturing

Inspira Technologies’ AI-Powered Blood Sensor Surpasses Expectations with Positive Clinical Data

Inspira Technologies’ AI-Powered Blood Sensor Surpasses Expectations with Positive Clinical Data PESG Research has released an update following the groundbreaking results from a clinical evaluation: Inspira Technologies (NASDAQ: IINN) has reported outstanding outcomes from its HYLA blood sensor study, achieving…

Read MoreInspira Technologies’ AI-Powered Blood Sensor Surpasses Expectations with Positive Clinical Data

PureHealth Partners with Abu Dhabi Early Childhood Authority for Child Healthcare Solutions

PureHealth Partners with Abu Dhabi Early Childhood Authority for Child Healthcare Solutions PureHealth has announced a strategic partnership with the Abu Dhabi Early Childhood Authority (ECA) to improve health outcomes for children throughout the UAE. The collaboration aims to enhance…

Read MorePureHealth Partners with Abu Dhabi Early Childhood Authority for Child Healthcare Solutions